Health Products

Spiriva (2013-10-07)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
107625Spiriva
Recalling Firm
Boehringer Ingelheim (Canada) Ltd.
5180 South Service Road
Burlington
L7L 5H4
Ontario
CANADA
Marketing Authorization Holder
Boehringer Ingelheim (Canada) Ltd.
5180 South Service Road
Burlington
L7L 5H4
Ontario
CANADA
CapsuleDIN 0224679318 μg tiotropium (22.5 μg tiotropium bromide monohydrate) per capsule

Introduction

Recalled Products

Spiriva

Reason

Drug substance material used to make drug product lots may be contaminated with extrinsic foreign particles.

Depth of distribution

Wholesalers across Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime